Joint Polish Investment Fund

What is Joint Polish Investment Fund?

The Joint Polish Investment Fund (JPIF) is a Life Science Venture Capital Fund based in Warsaw, Poland. It was established with the goal of investing in early and mid-stage life science companies.

Their focus is primarily on sectors such as medical, healthcare, mobile health, personalized health, and diagnostics. The investment fund's central thesis is to target companies that demonstrate visible and near-term value inflection points, ideally with a prospective holding period of 3-5 years. JPIF has a diversified team comprising scientists, medical doctors with industrial experience, plus experts trained in economics and business affairs.

Each team member harbors a genuine interest in life sciences and new technologies aimed at enhancing health, disease management, and quality of life.

In partnering with JPIF, entrepreneurs gain access to a knowledgeable advisory team and a global scientific and commercial network, accelerating preclinical, clinical, or commercial development and facilitating successful market entry into key healthcare markets in Europe, the U.S., and Asia.

The fund specializes in equity investments with a minimum investment threshold of €500,000.

Furthermore, JPIF invests with a clear communication and investment focus, promising mutual benefits from interactions between the firm and its portfolio companies. Their investment strategy covers various life science industries, including HealthTech, Fitness, Medical Devices, Hospital Services, Healthcare, Wellness, Investment Management, Nanotechnology, and other related fields. The management team prides itself on a long track record in sourcing, structuring, and selling businesses across all stages, from seed to revenue-generating companies.